Journal of Chromatography B 2005-05-05

Determination of WR-1065 in human blood by high-performance liquid chromatography following fluorescent derivatization by a maleimide reagent ThioGlo3.

Jun Chen, Zheng Lu, Theodore S Lawrence, David E Smith

Index: J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 819(1) , 161-7, (2005)

Full Text: HTML

Abstract

In order to improve the sensitivity and stability of human blood samples containing WR-1065 (i.e., active metabolite of the cytoprotective agent amifostine), a high-performance liquid chromatographic method was developed and validated using fluorescent derivatization with ThioGlo3. Using a sample volume of only 100 microl, the method was specific, sensitive (limit of quantitation=10 nM in deproteinized blood or 20 nM in whole blood), accurate (error < or = 3.2%) and reproducible (CV < or = 8.7%). In addition, the stability of WR-1065 in deproteinized and derivatized blood samples was assured for at least four weeks at -20 degrees C. This method should be particularly valuable in translating the kinetic-dynamic relationship of WR-1065 in preclinical models to that in cancer patients.

Related Compounds

  • WR-1065

Related Articles:

A manganese superoxide dismutase (SOD2)-mediated adaptive response.

2013-02-01

[Radiat. Res. 179(2) , 115-24, (2013)]

Aminothiol WR1065 induces differential gene expression in the presence of wild-type p53.

2005-06-02

[Oncogene 24(24) , 3964-75, (2005)]

Clinical pharmacokinetics of amifostine and WR1065 in pediatric patients with medulloblastoma.

2010-02-01

[Clin. Cancer Res. 16(3) , 1049-57, (2010)]

WR1065 mitigates AZT-ddI-induced mutagenesis and inhibits viral replication.

2009-07-01

[Environ. Mol. Mutagen. 50(6) , 460-72, (2009)]

Inhibition of human sperm respiration by 4-hydroperoxycyclophosphamide and protection by mesna and WR-1065

2009-01-01

[Fertil. Steril. 91(1) , 173-8, (2009)]

More Articles...